Source: Eur Respir J 2013; 42: 1438-1440



Rating:

Share or cite this content

Citations should be made in the following way:
Nadel Jay A.. The CFTR and EGFR relationship in airway vascular growth, and its importance in cystic fibrosis. Eur Respir J 2013; 42: 1438-1440

Member's Comments

No comment yet.

Related content which might interest you: Investigation of the status of cystic fibrosis airway epithelial cells Source: Annual Congress 2008 - Multigenic expression analyses: a guide for diagnosis and therapy Year: 2008 Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties via hydration Source: Eur Respir J, 59 (2) 2100185; 10.1183/13993003.00185-2021 Year: 2022 Atypical cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38 Year: 2006 Cross-talk of inflammatory mediators and airway epithelium reveals the cystic fibrosis transmembrane conductance regulator as a major target Source: ERJ Open Res, 7 (4) 00247-2021; 10.1183/23120541.00247-2021 Year: 2021 The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model Source: Eur Respir J, 52 (6) 1801133; 10.1183/13993003.01133-2018 Year: 2018 Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis Source: Eur Respir Rev 2013; 22: 58-65 Year: 2013 Expression of the nuclear factor-?B inhibitor A20 is altered in the cystic fibrosis epithelium Source: Eur Respir J 2013; 41: 1315-1323 Year: 2013 Cystic fibrosis transmembrane conductance regulator pharmacotherapy Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=88 Year: 2006 TLR-4 expression is reduced in cystic fibrosis bronchial epithelial cells Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Mechanisms and markers of airway inflammation in cystic fibrosis Source: Eur Respir J 2002; 19: 333-340 Year: 2002 Characterization of cystic fibrosis airway epithelium in vitro Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium Source: Eur Respir J 2013; 42: 1553-1562 Year: 2013 PP309 – Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 Endothelial dysfunction in cystic fibrosis: imbalance NOS/arginase? Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage Year: 2007 Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 MMP expression and abnormal lung permeability are important determinants of outcome in IPF Source: Eur Respir J 2009; 33: 77-84 Year: 2009 Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages Source: Eur Respir J, 57 (6) 2003502; 10.1183/13993003.03502-2020 Year: 2021